All lobbying filings

W Strategies, LLC

W Strategies, LLC filed a Q1 report for Incyte Corporation on April 18, 2026, reporting $60,000 in lobbying income.

Lobbying for Incyte Corporation · â€‹Biopharmaceutical Company.

As filed: W STRATEGIES, LLC for INCYTE CORPORATION.

All filings by W Strategies, LLC · Everything Incyte Corporation has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Delaware

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Education around access to innovative therapies in dermatology.

Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.

Bills named in this filing 1

H.R. 946
ORPHAN Cures Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.